Acetaminophen/Naproxen Sodium

对乙酰氨基酚/萘普生钠

Report date: 2024/07/03 21:31:43

Base Information

Drug NameAcetaminophen/Naproxen Sodium
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenasesCyclooxygenase-1Cyclooxygenase-2
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes AcetaminophenNaproxen Sodium
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson Consumer Inc
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A